Bruce Craven

Bruce Craven is a seasoned professional in the Biotechnology and Pharmaceutical industry, currently serving as Vice President at Valspec since October 2025. Prior experience includes serving as Executive Vice President - USA at PharmEng Technology from September 2017 to November 2025, where responsibilities involved providing a wide range of consulting services. Bruce held the position of President at Mangan Inc.'s BioPharm division from July 2011 to August 2017, focusing on Total Lifecycle Engineering. Additional roles include Vice President and General Manager at Vantage Consulting Group, Sr. Director at BE&K Engineering, and various positions at AMEC BioPharmaceuticals and Validation Associates Inc. Bruce’s educational background includes a BS in Microbiology from the University of South Carolina, an MS in Cellular Biology from East Carolina University, and a BS in Biology from The Citadel.